Insulin Resistance Syndrome: Difference between revisions

Latest revision as of 03:24, 17 November 2007

Redirect to:

Revision as of 18:14, 26 January 2007 (view source) imported>Nancy Sculerati MD No edit summary		Latest revision as of 03:24, 17 November 2007 (view source) imported>Pierre-Alain Gouanvic (Redirecting to Metabolic syndrome)
(7 intermediate revisions by 6 users not shown)
Line 1:		Line 1:
	~~The '''insulin resistance syndrome''' is a "constellation of findings, including~~ [[~~central obesity]], [[glucose intolerance]], [[dyslipidemia]], and [[hypertension]], that promotes the development of [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer\|cancer~~]], polycystic ovarian disease (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology		#REDIRECT [[Metabolic syndrome]]
	~~Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723))~~